Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Allison

Showing results (511-520 of 647) with videos related to

Pageof 65
Sort By:
Cancer Research|May 20, 2016
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor RejectionTodd C Metzger, Hua Long, Shobha Potluri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trialBradley C Carthon, Jedd D Wolchok, Jianda Yuan, et al.
Environmental Science & Technology|June 1, 2010
Silver nanocrystallites: biofabrication using Shewanella oneidensis, and an evaluation of their comparative toxicity on gram-negative and gram-positive bacteriaAnil K Suresh, Dale A Pelletier, Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell functionPeter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.
The Journal of Clinical Investigation|June 16, 2018
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapySangeeta Goswami, Irina Apostolou, Jan Zhang, et al.
Acta Biomaterialia|January 19, 2011
Biofabrication of discrete spherical gold nanoparticles using the metal-reducing bacterium Shewanella oneidensisAnil K Suresh, Dale A Pelletier, Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid MalignanciesIssa F Khouri, Irina Fernandez Curbelo, Francesco Turturro, et al.
Acta Biomaterialia|July 30, 2011
Monodispersed biocompatible silver sulfide nanoparticles: facile extracellular biosynthesis using the γ-proteobacterium, Shewanella oneidensisAnil K Suresh, Mitchel J Doktycz, Wei Wang, et al.
Annals of Surgical Oncology|May 18, 2013
Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanomaDavid E Gyorki, Jianda Yuan, Zhenyu Mu, et al.
Genomics|May 1, 1997
Mapping individual cosmid DNAs by direct AFM imagingD P Allison, P S Kerper, M J Doktycz, et al.
Pageof 65

Showing results (511-520 of 647) with videos related to

Sort By:
Pageof 65
Cancer Research|May 20, 2016
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor RejectionTodd C Metzger, Hua Long, Shobha Potluri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trialBradley C Carthon, Jedd D Wolchok, Jianda Yuan, et al.
Environmental Science & Technology|June 1, 2010
Silver nanocrystallites: biofabrication using Shewanella oneidensis, and an evaluation of their comparative toxicity on gram-negative and gram-positive bacteriaAnil K Suresh, Dale A Pelletier, Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell functionPeter E Fecci, Hidenobu Ochiai, Duane A Mitchell, et al.
The Journal of Clinical Investigation|June 16, 2018
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapySangeeta Goswami, Irina Apostolou, Jan Zhang, et al.
Acta Biomaterialia|January 19, 2011
Biofabrication of discrete spherical gold nanoparticles using the metal-reducing bacterium Shewanella oneidensisAnil K Suresh, Dale A Pelletier, Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid MalignanciesIssa F Khouri, Irina Fernandez Curbelo, Francesco Turturro, et al.
Acta Biomaterialia|July 30, 2011
Monodispersed biocompatible silver sulfide nanoparticles: facile extracellular biosynthesis using the γ-proteobacterium, Shewanella oneidensisAnil K Suresh, Mitchel J Doktycz, Wei Wang, et al.
Annals of Surgical Oncology|May 18, 2013
Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanomaDavid E Gyorki, Jianda Yuan, Zhenyu Mu, et al.
Genomics|May 1, 1997
Mapping individual cosmid DNAs by direct AFM imagingD P Allison, P S Kerper, M J Doktycz, et al.
Pageof 65